Skip to content
Open access

Joint contributions of metabolic dysfunction and biological aging to cardiometabolic multimorbidity and disease progression: a prospective cohort study

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

TyG BA composites provide a parsimonious summary of combined metabolic-aging burden and improve risk discrimination beyond conventional clinical factors, but should not be interpreted as superior to models retaining TyG and biological age separately.

Read PDF

Similar papers

Open access Aug 2026

Cumulative lipid–inflammatory indices and the risk of cardiometabolic multimorbidity: a prospective cohort study

Background Cardiometabolic multimorbidity (CMM) has become a major global public health challenge. Although dyslipidemia and chronic low-grade inflammation are known to contribute to cardiometabolic diseases, their long-term cumulative combined effects on the risk of CMM remain poorly understood. This study aimed to ev...

Li-Jun Meng, Hai-Bo Gao, Jing Yang et al. · 0 citations
Open access Oct 2026

Impact of lipid accumulation product on cardiometabolic multimorbidity and the mediating effect of leukocytes: evidence from a prospective cohort study among middle-aged and elderly chinese adults

Cardiometabolic multimorbidity (CMM) is a growing public-health burden in ageing populations, yet conventional adiposity measures such as body mass index and waist circumference do not adequately capture the visceral fat and lipid-metabolic disturbances that underlie it. We investigated the association between the lipi...

Awakere Maiturouze, Yun-Jia Li, Dan-Meng Li · 0 citations
Open access Sep 2026

Estimated glucose disposal rate shows the broadest associations with cardiometabolic multimorbidity progression in early cardiovascular–kidney–metabolic stages: a longitudinal cohort study

Early risk stratification may help prevent cardiometabolic multimorbidity (CMM) among adults at cardiovascular–kidney–metabolic (CKM) stages 0–3. We compared the estimated glucose disposal rate (eGDR), triglyceride–glucose (TyG) index, and atherogenic index of plasma (AIP) for incident CMM, disease transitions, and...

Zun-Wei Wang, Yan-Yan Liu, Yi-Tong Ling et al. · 0 citations
Review Aug 2026

Associations of biological aging and biological age acceleration with mortality in patients with cardiorenal syndrome: A prospective cohort study.

KDM-BA, KDM-BA, PhenoAge, KDM-BAA, and PhenoAgeAccel are significantly associated with all-cause mortality among the CRS population, with a non-linear relationship observed in cerebrovascular disease.

Xin-Tong Yang, Yu-Rong Zhang, Y. Zhong et al. · 0 citations
Sep 2026

Combined associations of triglyceride-glucose index and biochemical sarcopenia index with cardiometabolic multimorbidity in middle-aged and older Chinese adults.

BACKGROUND Cardiometabolic multimorbidity confers a substantial disease burden in middle-aged and older adults. The triglyceride-glucose index is a reliable marker of insulin resistance, while the biochemical sarcopenia index reflects skeletal muscle mass. However, their combined association with cardiometabolic multim...

Yan Chen, Jun Chen, Zi-Jia Meng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.